Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.
Source link
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Date:
More like thisRelated
Trump takes aim at Pope Leo, calling him “WEAK on Crime, and terrible for Foreign Policy.”
President Trump lashed out at...
Inaugural New Mexico Ranch Fest kicks off
ALBUQUERQUE, N.M. (KRQE) – People got to experience a taste of...
McDonald’s to Add Energy Drinks, Crafted Sodas to Menus
A Mango Pineapple Refresher and Red Bull Dragonberry Energizer...